APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alfacalcidol Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Alfacalcidol Tablets Market Outlook and Growth Opportunities 2026

27 December 2025199 pages

Choose your research edition.

Industry ResearchAlfacalcidol Tablets Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Alfacalcidol Tablets Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Alfacalcidol Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alfacalcidol Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Alfacalcidol Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Alfacalcidol Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Alfacalcidol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alfacalcidol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alfacalcidol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Alfacalcidol Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Alfacalcidol Tablets market include Merck Europe B.V., Mylan Pharmaceuticals, Pfizer Inc., Santen Pharmaceutical Co.,Ltd., Teva Takeda Yakuhin Ltd., Organon LLC and LTL Pharma Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Alfacalcidol Tablets market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alfacalcidol Tablets and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alfacalcidol Tablets revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Alfacalcidol Tablets market.

Alfacalcidol Tablets Segment by Company

Merck Europe B.V.

Mylan Pharmaceuticals

Pfizer Inc.

Santen Pharmaceutical Co.,Ltd.

Teva Takeda Yakuhin Ltd.

Organon LLC

LTL Pharma Co., Ltd.

Alfacalcidol Tablets Segment by Type

0.25μg

0.5μg

1.0μg

Alfacalcidol Tablets Segment by Application

Hospital

Clinic

Others

Alfacalcidol Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Alfacalcidol Tablets status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Alfacalcidol Tablets key companies, revenue, market share, and recent developments.

3. To split the Alfacalcidol Tablets breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Alfacalcidol Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alfacalcidol Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Alfacalcidol Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alfacalcidol Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alfacalcidol Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alfacalcidol Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alfacalcidol Tablets industry.

Chapter 3: Detailed analysis of Alfacalcidol Tablets company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Alfacalcidol Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Alfacalcidol Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alfacalcidol Tablets Industry Trends Table 2. Alfacalcidol Tablets Industry Drivers Table 3. Alfacalcidol Tablets Industry Opportunities and Challenges Table 4. Alfacalcidol Tablets Industry Restraints Table 5. Global Alfacalcidol Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alfacalcidol Tablets Revenue Share by Company (2021-2026) Table 7. Global Alfacalcidol Tablets Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Alfacalcidol Tablets Key Company Manufacturing Base & Headquarters Table 9. Global Alfacalcidol Tablets Company, Product Type & Application Table 10. Global Alfacalcidol Tablets Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Alfacalcidol Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 0.25μg Table 15. Significant Companies of 0.5μg Table 16. Significant Companies of 1.0μg Table 17. Global Alfacalcidol Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Alfacalcidol Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Alfacalcidol Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Alfacalcidol Tablets Sales Value Share by Type (2021-2026) Table 21. Global Alfacalcidol Tablets Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Clinic Table 24. Significant Companies of Others Table 25. Global Alfacalcidol Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Alfacalcidol Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Alfacalcidol Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Alfacalcidol Tablets Sales Value Share by Application (2021-2026) Table 29. Global Alfacalcidol Tablets Sales Value Share by Application (2027-2032) Table 30. Global Alfacalcidol Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Alfacalcidol Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Alfacalcidol Tablets Sales Value Share by Region (2021-2026) Table 33. Global Alfacalcidol Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Alfacalcidol Tablets Sales Value Share by Region (2027-2032) Table 35. Global Alfacalcidol Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Alfacalcidol Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Alfacalcidol Tablets Sales Value Market Share by Country (2021-2026) Table 38. Global Alfacalcidol Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Alfacalcidol Tablets Sales Value Market Share by Country (2027-2032) Table 40. Merck Europe B.V. Company Information Table 41. Merck Europe B.V. Business Overview Table 42. Merck Europe B.V. Alfacalcidol Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Merck Europe B.V. Alfacalcidol Tablets Product Portfolio Table 44. Merck Europe B.V. Recent Development Table 45. Mylan Pharmaceuticals Company Information Table 46. Mylan Pharmaceuticals Business Overview Table 47. Mylan Pharmaceuticals Alfacalcidol Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Mylan Pharmaceuticals Alfacalcidol Tablets Product Portfolio Table 49. Mylan Pharmaceuticals Recent Development Table 50. Pfizer Inc. Company Information Table 51. Pfizer Inc. Business Overview Table 52. Pfizer Inc. Alfacalcidol Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Pfizer Inc. Alfacalcidol Tablets Product Portfolio Table 54. Pfizer Inc. Recent Development Table 55. Santen Pharmaceutical Co.,Ltd. Company Information Table 56. Santen Pharmaceutical Co.,Ltd. Business Overview Table 57. Santen Pharmaceutical Co.,Ltd. Alfacalcidol Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Santen Pharmaceutical Co.,Ltd. Alfacalcidol Tablets Product Portfolio Table 59. Santen Pharmaceutical Co.,Ltd. Recent Development Table 60. Teva Takeda Yakuhin Ltd. Company Information Table 61. Teva Takeda Yakuhin Ltd. Business Overview Table 62. Teva Takeda Yakuhin Ltd. Alfacalcidol Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Teva Takeda Yakuhin Ltd. Alfacalcidol Tablets Product Portfolio Table 64. Teva Takeda Yakuhin Ltd. Recent Development Table 65. Organon LLC Company Information Table 66. Organon LLC Business Overview Table 67. Organon LLC Alfacalcidol Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Organon LLC Alfacalcidol Tablets Product Portfolio Table 69. Organon LLC Recent Development Table 70. LTL Pharma Co., Ltd. Company Information Table 71. LTL Pharma Co., Ltd. Business Overview Table 72. LTL Pharma Co., Ltd. Alfacalcidol Tablets Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. LTL Pharma Co., Ltd. Alfacalcidol Tablets Product Portfolio Table 74. LTL Pharma Co., Ltd. Recent Development Table 75. Research Programs/Design for This Report Table 76. Authors List of This Report Table 77. Secondary Sources Table 78. Primary Sources List of Figures Figure 1. Alfacalcidol Tablets Product Image Figure 2. Global Alfacalcidol Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alfacalcidol Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Alfacalcidol Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 0.25μg Image Figure 8. 0.5μg Image Figure 9. 1.0μg Image Figure 10. Global Alfacalcidol Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Alfacalcidol Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Alfacalcidol Tablets Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Others Image Figure 16. Global Alfacalcidol Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Alfacalcidol Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Alfacalcidol Tablets Sales Value Share by Application (2021-2032) Figure 19. Global Alfacalcidol Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Alfacalcidol Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Alfacalcidol Tablets Sales Value (2021-2032) & (US$ Million) Figure 22. North America Alfacalcidol Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Alfacalcidol Tablets Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Alfacalcidol Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Alfacalcidol Tablets Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Alfacalcidol Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Alfacalcidol Tablets Sales Value (2021-2032) & (US$ Million) Figure 28. South America Alfacalcidol Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Alfacalcidol Tablets Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Alfacalcidol Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Alfacalcidol Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25μg
  • 0.5μg
  • 1.0μg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Merck Europe B.V.
  • Mylan Pharmaceuticals
  • Pfizer Inc.
  • Santen Pharmaceutical Co.,Ltd.
  • Teva Takeda Yakuhin Ltd.
  • Organon LLC
  • LTL Pharma Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alfacalcidol Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alfacalcidol Tablets Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Alfacalcidol Tablets Market Dynamics
  1. 2.1 Alfacalcidol Tablets Industry Trends
  2. 2.2 Alfacalcidol Tablets Industry Drivers
  3. 2.3 Alfacalcidol Tablets Industry Opportunities and Challenges
  4. 2.4 Alfacalcidol Tablets Industry Restraints
3 Alfacalcidol Tablets Market by Company
  1. 3.1 Global Alfacalcidol Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Alfacalcidol Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Alfacalcidol Tablets Company Ranking (2024-2026)
  4. 3.4 Global Alfacalcidol Tablets Company Manufacturing Base and Headquarters
  5. 3.5 Global Alfacalcidol Tablets Company Product Type and Application
  6. 3.6 Global Alfacalcidol Tablets Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Alfacalcidol Tablets Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Alfacalcidol Tablets Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Alfacalcidol Tablets Market by Type
  1. 4.1 Alfacalcidol Tablets Type Introduction
  2. 4.1.1 0.25μg
  3. 4.1.2 0.5μg
  4. 4.1.3 1.0μg
  5. 4.2 Global Alfacalcidol Tablets Sales Value by Type
  6. 4.2.1 Global Alfacalcidol Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Alfacalcidol Tablets Sales Value by Type (2021-2032)
  8. 4.2.3 Global Alfacalcidol Tablets Sales Value Share by Type (2021-2032)
5 Alfacalcidol Tablets Market by Application
  1. 5.1 Alfacalcidol Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Alfacalcidol Tablets Sales Value by Application
  6. 5.2.1 Global Alfacalcidol Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alfacalcidol Tablets Sales Value by Application (2021-2032)
  8. 5.2.3 Global Alfacalcidol Tablets Sales Value Share by Application (2021-2032)
6 Alfacalcidol Tablets Regional Value Analysis
  1. 6.1 Global Alfacalcidol Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alfacalcidol Tablets Sales Value by Region (2021-2032)
  3. 6.2.1 Global Alfacalcidol Tablets Sales Value by Region: 2021-2026
  4. 6.2.2 Global Alfacalcidol Tablets Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alfacalcidol Tablets Sales Value (2021-2032)
  7. 6.3.2 North America Alfacalcidol Tablets Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Alfacalcidol Tablets Sales Value (2021-2032)
  10. 6.4.2 Europe Alfacalcidol Tablets Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Alfacalcidol Tablets Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Alfacalcidol Tablets Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Alfacalcidol Tablets Sales Value (2021-2032)
  16. 6.6.2 South America Alfacalcidol Tablets Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Alfacalcidol Tablets Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Alfacalcidol Tablets Sales Value Share by Country, 2025 VS 2032
7 Alfacalcidol Tablets Country-level Value Analysis
  1. 7.1 Global Alfacalcidol Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alfacalcidol Tablets Sales Value by Country (2021-2032)
  3. 7.2.1 Global Alfacalcidol Tablets Sales Value by Country (2021-2026)
  4. 7.2.2 Global Alfacalcidol Tablets Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Alfacalcidol Tablets Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Alfacalcidol Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Alfacalcidol Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck Europe B.V.
  2. 8.1.1 Merck Europe B.V. Company Information
  3. 8.1.2 Merck Europe B.V. Business Overview
  4. 8.1.3 Merck Europe B.V. Alfacalcidol Tablets Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Europe B.V. Alfacalcidol Tablets Product Portfolio
  6. 8.1.5 Merck Europe B.V. Recent Developments
  7. 8.2 Mylan Pharmaceuticals
  8. 8.2.1 Mylan Pharmaceuticals Company Information
  9. 8.2.2 Mylan Pharmaceuticals Business Overview
  10. 8.2.3 Mylan Pharmaceuticals Alfacalcidol Tablets Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Pharmaceuticals Alfacalcidol Tablets Product Portfolio
  12. 8.2.5 Mylan Pharmaceuticals Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Alfacalcidol Tablets Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Alfacalcidol Tablets Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 Santen Pharmaceutical Co.,Ltd.
  20. 8.4.1 Santen Pharmaceutical Co.,Ltd. Company Information
  21. 8.4.2 Santen Pharmaceutical Co.,Ltd. Business Overview
  22. 8.4.3 Santen Pharmaceutical Co.,Ltd. Alfacalcidol Tablets Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Santen Pharmaceutical Co.,Ltd. Alfacalcidol Tablets Product Portfolio
  24. 8.4.5 Santen Pharmaceutical Co.,Ltd. Recent Developments
  25. 8.5 Teva Takeda Yakuhin Ltd.
  26. 8.5.1 Teva Takeda Yakuhin Ltd. Company Information
  27. 8.5.2 Teva Takeda Yakuhin Ltd. Business Overview
  28. 8.5.3 Teva Takeda Yakuhin Ltd. Alfacalcidol Tablets Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teva Takeda Yakuhin Ltd. Alfacalcidol Tablets Product Portfolio
  30. 8.5.5 Teva Takeda Yakuhin Ltd. Recent Developments
  31. 8.6 Organon LLC
  32. 8.6.1 Organon LLC Company Information
  33. 8.6.2 Organon LLC Business Overview
  34. 8.6.3 Organon LLC Alfacalcidol Tablets Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Organon LLC Alfacalcidol Tablets Product Portfolio
  36. 8.6.5 Organon LLC Recent Developments
  37. 8.7 LTL Pharma Co., Ltd.
  38. 8.7.1 LTL Pharma Co., Ltd. Company Information
  39. 8.7.2 LTL Pharma Co., Ltd. Business Overview
  40. 8.7.3 LTL Pharma Co., Ltd. Alfacalcidol Tablets Revenue and Gross Margin (2021-2026)
  41. 8.7.4 LTL Pharma Co., Ltd. Alfacalcidol Tablets Product Portfolio
  42. 8.7.5 LTL Pharma Co., Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst